A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And Lymphomas
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
The First Affiliated Hospital of Soochow University
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Beijing Tongren Hospital
OHSU Knight Cancer Institute
Therapeutic Advances in Childhood Leukemia Consortium
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
University of Washington